Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum and dietary fatty acids and their relationship to vascular inflammation and carotid intima-media thickness: implications for cardiovascular risk in patients with arterial hypertension.

Acta cardiologica·2025
Same author

Impact of Freezing, Storage, and Pasteurization on Nutritional Components and Redox Biomarkers in Human Milk Donations.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2025
Same author

Exclusive human milk diet: a challenging innovation in neonatal care.

Journal of medical economics·2024
Same author

Study of anti-tumorigenic actions of essential fatty acids in a murine mammary gland adenocarcinoma by micro-XRF.

Analytical methods : advancing methods and applications·2023
Same author

COVID-19-related stress in postpartum women from Argentina during the second wave in 2021: Identification of impairing and protective factors.

Midwifery·2022
Same author

Memory enhancement in Argentinian women during postpartum by the dietary intake of lignans and anthocyanins.

Nutrition research (New York, N.Y.)·2020
Same journal

A double threat.

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026
Same journal

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026
Same journal

Effectiveness of strategies to prevent burnout syndrome in hospital-based healthcare personnel.

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026
Same journal

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026
Same journal

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026
Same journal

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

[Cellular therapy: regeneration and reprogramming]

Aldo R Eynard, Elio A Soria

    Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)
    |June 12, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
    13:58

    Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

    Published on: July 29, 2015

    Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
    11:42

    Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

    Published on: November 4, 2019

    Related Experiment Videos

    Last Updated: May 10, 2026

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
    10:04

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

    Published on: August 1, 2025

    Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells
    13:58

    Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

    Published on: July 29, 2015

    Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
    11:42

    Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

    Published on: November 4, 2019